CPX-351 in Higher Risk Myelodysplastic Syndromes
Clinical trial NCT04273802 · COMPLETED
Trial details
- NCT number
- NCT04273802
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-29
- Primary completion
- 2021-08-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.